B.S. Candidate in Biomedical Engineering, Class of 2025

Alejandro is an undergraduate student majoring in biomedical engineering and philosophy with a concentration in immunoengineering. In 2022, he received the Kam Leong Undergraduate Research Fellowship, during which he was mentored by Chenhu Qiu to develop a controlled-release nanodelivery system for a diabetic drug, Semaglutide, that preserved bioactivity using the sequential flash nanocomplexation and flash nanoprecipitation (sFNC/FNP) protocol. Alejandro currently works on an in vivo artificial T cell-stimulating matrix (aTM) loaded with 6-diazo-5-oxo-L-norleucine (DON) nanoparticles to metabolically optimize T cells for cancer immunotherapy with Joseph Choy. Alejandro is the co-founder and president of Phagogen, where he is engineering tumor antigen-expressing bacteriophages loaded in a nanofiber-hydrogel composite as a potent, adjuvant-free cancer vaccine vector. Outside of the lab, Alejandro enjoys music composition, trying new foods, attending concerts, and watching anime.